SofWave Medical Ltd.
Tel Aviv Stock ExchangeTotal Valuation
SofWave Medical Ltd. carries a market capitalization of 1.54B, placing it among publicly traded companies globally. Its enterprise value stands at 42.04B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.54B |
| Enterprise Value | 42.04B |
Share Statistics
SofWave Medical Ltd. currently has 36.10M shares outstanding.
| Shares Outstanding | 36.10M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
SofWave Medical Ltd. trades at a trailing price-to-earnings ratio of 6,116.96. The price-to-sales ratio is 566.25, and the price-to-book ratio stands at -820.53.
| PE Ratio | 6,116.96 |
| PS Ratio | 566.25 |
| PB Ratio | -820.53 |
| P/TBV Ratio | 1,202.24 |
| P/FCF Ratio | 3,938.97 |
| P/OCF Ratio | 3,688.30 |
Enterprise Valuation
On an enterprise value basis, SofWave Medical Ltd. trades at an EV/EBITDA multiple of 5,279.32 and an EV/FCF ratio of 3,561.38. The EV/Sales ratio of 565.80 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 5,279.32 provides insight into valuation relative to core operating earnings.
| EV / Sales | 565.80 |
| EV / EBITDA | 5,279.32 |
| EV / EBIT | 5,279.32 |
| EV / FCF | 3,561.38 |
Financial Position
SofWave Medical Ltd. maintains a current ratio of 2.43, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.07, indicating elevated leverage, while an interest coverage ratio of -42.36 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.43 |
| Quick Ratio | 1.60 |
| Debt / Equity | 4.07 |
| Debt / EBITDA | 0.18 |
| Interest Coverage | -42.36 |
Financial Efficiency
SofWave Medical Ltd. posts a return on equity of -5.74 and a return on invested capital of 24.91.
| Return on Equity (ROE) | -5.74 |
| Return on Assets (ROA) | 13.78 |
| Return on Invested Capital (ROIC) | 24.91 |
| Return on Capital Employed (ROCE) | -12.45 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.10 |
Taxes
Over the trailing twelve months, SofWave Medical Ltd. has paid 196,000.00 in income taxes, reflecting an effective tax rate of 2.77.
| Income Tax | 196,000.00 |
| Effective Tax Rate | 2.77 |
Stock Price Statistics
SofWave Medical Ltd.'s stock has gained approximately 88.38652% over the past 52 weeks. The 50-day moving average sits at 4,273.12, while the 200-day moving average is 3,545.99.
| Beta (5Y) | N/A |
| 52-Week Price Change | 88.38652% |
| 50-Day Moving Average | 4,273.12 |
| 200-Day Moving Average | 3,545.99 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, SofWave Medical Ltd. generated 74.30M in revenue and converted that into 6.88M in net income, yielding earnings per share of 0.17. EBITDA reached 7.96M, while operating income came in at 7.96M.
| Revenue | 74.30M |
| Gross Profit | 56.01M |
| Operating Income | 7.96M |
| Pretax Income | 7.07M |
| Net Income | 6.88M |
| EBITDA | 7.96M |
| EBIT | 7.96M |
| Earnings Per Share (EPS) | 0.17 |
Balance Sheet
SofWave Medical Ltd. holds 34.64M in cash and equivalents against 1.43M in total debt, resulting in a net debt position of -34.62M. Total book value stands at -51.27M, with working capital of 31.01M providing operational flexibility.
| Cash & Cash Equivalents | 34.64M |
| Total Debt | 1.43M |
| Net Debt | -34.62M |
| Equity (Book Value) | -51.27M |
| Book Value Per Share | -1.44 |
| Working Capital | 31.01M |
Cash Flow
SofWave Medical Ltd. produced 11.41M in operating cash flow over the past twelve months. After subtracting -580,000.00 in capital expenditures, free cash flow totaled 10.83M - equivalent to 0.30 per share.
| Operating Cash Flow | 11.41M |
| Capital Expenditures | -580,000.00 |
| Free Cash Flow | 10.83M |
| FCF Per Share | 0.30 |
Margins
SofWave Medical Ltd. operates with a gross margin of 75.38, reflecting its pricing power and cost economics. The operating margin of 10.72 and net profit margin of 9.26 provide insight into operational efficiency.
| Gross Margin | 75.38 |
| Operating Margin | 10.72 |
| Pretax Margin | 9.52 |
| Profit Margin | 9.26 |
| EBITDA Margin | 10.72 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.00 |
| FCF Yield | 0.03 |
Scores
SofWave Medical Ltd. posts an Altman Z-Score of 1,110.84, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1,110.84 |